Chad M. Robins
CEO and Chairman, Director · Adaptive Biotechnologies Corp
- 2025
- Aug 20, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Chad M. Robins files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Harlan S. Robins - $29.48M in ADPT purchases and sales in the last 12 months
- Julie Rubinstein - $16.25M in ADPT purchases and sales in the last 12 months
- Sharon Benzeno - $14.48M in ADPT purchases and sales in the last 12 months
- Francis Lo - $11.99M in ADPT purchases and sales in the last 12 months
- Kyle Piskel - $3.58M in ADPT purchases and sales in the last 12 months
- Peter M. Neupert - $3.14M in ADPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Chad M. Robins?
Chad M. Robins is a corporate insider, tracked as CEO and Chairman, Director of Adaptive Biotechnologies Corp (ADPT). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Chad M. Robins submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Chad M. Robins been buying or selling stock?
Recorded transactions: 0 open-market purchases and 18 open-market sales ($37.85M) across all tracked filings.
